IL-8 Signaling Plays a Critical Role in the Epithelial-Mesenchymal Transition of Human Carcinoma Cells

被引:349
作者
Fernando, Romaine I. [1 ]
Castillo, Marianne D. [1 ]
Litzinger, Mary [1 ]
Hamilton, Duane H. [1 ]
Palena, Claudia [1 ]
机构
[1] NCI, Tumor Immunol & Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
关键词
BREAST-CARCINOMA; TUMOR-GROWTH; METASTATIC PHENOTYPE; SERUM INTERLEUKIN-8; MALIGNANT-MELANOMA; PROSTATE-CANCER; STEM-CELLS; IN-VITRO; EXPRESSION; PROGRESSION;
D O I
10.1158/0008-5472.CAN-11-0156
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The switch of tumor cells from an epithelial to a mesenchymal-like phenotype [designated as epithelial-to-mesenchymal transition (EMT)] is known to induce tumor cell motility and invasiveness, therefore promoting metastasis of solid carcinomas. Although multiple studies have focused on elucidating the signaling events that initiate this phenotypic switch, there has been so far no characterization of the pattern of soluble mediators released by tumor cells undergoing EMT, and the potential impact that this phenotypic switch could have on the remodeling of the tumor microenvironment. Here we show that induction of EMT in human carcinoma cells via overexpression of the transcription factor Brachyury is associated with enhanced secretion of multiple cytokines, chemokines, and angiogenic factors and, in particular, with the induction of the IL-8/IL-8R axis. Our results also indicate the essential role of interleukin 8 (IL-8) signaling for the acquisition and/or maintenance of the mesenchymal and invasive features of Brachyury-overexpressing tumor cells and show that IL-8 secreted by tumor cells undergoing EMT could potentiate tumor progression by inducing adjacent epithelial tumor cells into EMT. Altogether, our results emphasize the potential role of EMT in the modulation of the tumor microenvironment via secretion of multiple soluble mediators and suggest that IL-8 signaling blockade may provide a means of targeting mesenchymal-like, invasive tumor cells. Cancer Res; 71(15); 5296-306. (C) 2011 AACR.
引用
收藏
页码:5296 / 5306
页数:11
相关论文
共 44 条
[1]
Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis [J].
Ancrile, Brooke ;
Lim, Kian-Huat ;
Counter, Christopher M. .
GENES & DEVELOPMENT, 2007, 21 (14) :1714-1719
[2]
Smoldering and polarized inflammation in the initiation and promotion of malignant disease [J].
Balkwill, F ;
Charles, KA ;
Mantovani, A .
CANCER CELL, 2005, 7 (03) :211-217
[3]
Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival [J].
Benoy, IH ;
Salgado, R ;
Van Dam, P ;
Geboers, K ;
Van Marck, E ;
Scharpé, S ;
Vermeulen, PB ;
Dirix, LY .
CLINICAL CANCER RESEARCH, 2004, 10 (21) :7157-7162
[4]
Correlation of Snail expression with histological grade and lymph node status in breast carcinomas [J].
Blanco, MJ ;
Moreno-Bueno, G ;
Sarrio, D ;
Locascio, A ;
Cano, A ;
Palacios, J ;
Nieto, MA .
ONCOGENE, 2002, 21 (20) :3241-3246
[5]
Epithelial mesenchymal transition traits in human breast cancer cell lines [J].
Blick, T. ;
Widodo, E. ;
Hugo, H. ;
Waltham, M. ;
Lenburg, M. E. ;
Neve, R. M. ;
Thompson, E. W. .
CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 (06) :629-642
[6]
Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature [J].
Charafe-Jauffret, Emmanuelle ;
Ginestier, Christophe ;
Iovino, Flora ;
Wicinski, Julien ;
Cervera, Nathalie ;
Finetti, Pascal ;
Hur, Min-Hee ;
Diebel, Mark E. ;
Monville, Florence ;
Dutcher, Julie ;
Brown, Marty ;
Viens, Patrice ;
Xerri, Luc ;
Bertucci, Francois ;
Stassi, Giorgio ;
Dontu, Gabriela ;
Birnbaum, Daniel ;
Wicha, Max S. .
CANCER RESEARCH, 2009, 69 (04) :1302-1313
[7]
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor [J].
Coppe, Jean-Philippe ;
Patil, Christopher K. ;
Rodier, Francis ;
Sun, Yu ;
Munoz, Denise P. ;
Goldstein, Joshua ;
Nelson, Peter S. ;
Desprez, Pierre-Yves ;
Campisi, Judith .
PLOS BIOLOGY, 2008, 6 (12) :2853-2868
[8]
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features [J].
Creighton, Chad J. ;
Li, Xiaoxian ;
Landis, Melissa ;
Dixon, J. Michael ;
Neumeister, Veronique M. ;
Sjolund, Ashley ;
Rimm, David L. ;
Wong, Helen ;
Rodriguez, Angel ;
Herschkowitz, Jason I. ;
Fan, Cheng ;
Zhang, Xiaomei ;
He, Xiaping ;
Pavlick, Anne ;
Gutierrez, M. Carolina ;
Renshaw, Lorna ;
Larionov, Alexey A. ;
Faratian, Dana ;
Hilsenbeck, Susan G. ;
Perou, Charles M. ;
Lewis, Michael T. ;
Rosen, Jeffrey M. ;
Chang, Jenny C. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (33) :13820-13825
[9]
The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERβ, and enhances expression of oncogenic cytokine GRO [J].
Dannenmann, Christine ;
Shabani, Naim ;
Friese, Klaus ;
Jeschke, Udo ;
Mylonas, Ioannis ;
Bruening, Ansgar .
CANCER BIOLOGY & THERAPY, 2008, 7 (09) :1462-1469
[10]
A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells [J].
De Larco, JE ;
Wuertz, BRK ;
Rosner, KA ;
Erickson, SA ;
Gamache, DE ;
Manivel, JC ;
Furcht, LT .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (02) :639-+